Disease Model Screening
Disease Model Screening is a phenotypic screening approach that employs biologically relevant models of human disease to identify compounds or genetic perturbations with therapeutic potential based on their ability to modify disease-associated phenotypes.
33
Publications
1.8K
Citations
252
Authors
104
Institutions
Publications per year
2017–2026
12
Parents
33
Zebrafish: from disease modeling to drug discovery.
Amy L. Rubinstein · PubMed · 2003 · 210 citations
Biowire Model of Interstitial and Focal Cardiac Fibrosis
Erika Yan Wang, Naimeh Rafatian, Yimu Zhao et al. · ACS Central Science · 2019 · 131 citations · Full text
Medicine, Bioengineering, Cardiology +16
1–5 of 33
252
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 252
104
Inserm
Paris, France
3 h-index
5 publications
898 citations

Howard Hughes Medical Institute
Chevy Chase, United States
3 h-index
3 publications
247 citations

Broad Institute
Cambridge, United States
2 h-index
16 publications
1.1K citations

Centre National de la Recherche Scientifique
Paris, France
2 h-index
4 publications
862 citations
University of California San Diego
San Diego, United States
2 h-index
3 publications
155 citations
Baylor College of Medicine
Houston, United States
2 h-index
8 publications
1.6K citations
Bayer (Germany)
Leverkusen, Germany
2 h-index
12 publications
360 citations

Boston Children's Hospital
Boston, United States
2 h-index
12 publications
896 citations
1–8 of 104
Repository · 3 publications · 278 citations
3
h-index
2 publications · 67 citations
2
h-index
2 publications · 179 citations
2
h-index
1 publications · 38 citations
1
h-index
PBP · 1 publications · 39 citations
1
h-index
1–5